News & Media
-
May 31, 2025
Pre-surgical combination therapy shows promising results for NSCLC
UT MD Anderson News Release
-
October 21, 2023
ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer
UT MD Anderson News Release
-
September 14, 2023
Combination immunotherapy treatment effective before lung cancer surgery
UT MD Anderson News Release
-
March 16, 2023
Dual immunotherapy plus chemotherapy before surgery improves patient outcomes in operable lung cancer
UT MD Anderson News Release
-
April 11, 2022
AACR: Combination immunotherapy treatment effective before lung cancer surgery
UT MD Anderson News Release
-
February 18, 2021
Neoadjuvant combination immunotherapy improves outcomes for early stage non-small cell lung cancer -- Cascone T and Sepesi B.
UT MD Anderson News Release
-
Nov. 20, 2020
UT MD Anderson researchers present immunotherapy advances at Society for Immunotherapy of Cancer Annual Meeting. Highlights include positive clinical data from combination therapies in patients with melanoma and lung cancer - Cascone T and Sepesi B.
UT MD Anderson News Release
Give Now
Research Areas
Find out about the four types of research taking place at UT?MD Anderson.